{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T16:04:09Z","timestamp":1779984249468,"version":"3.53.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T00:00:00Z","timestamp":1777420800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T00:00:00Z","timestamp":1779926400000},"content-version":"vor","delay-in-days":29,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08186-y","type":"journal-article","created":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T16:54:27Z","timestamp":1777481667000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A contamination-adjusted tissue thrombopoietic framework identifies a clinically relevant CAF\u2013myeloid niche in non-small cell lung cancer: a paired transcriptomic and survival study"],"prefix":"10.1186","volume":"24","author":[{"given":"Guocai","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofei","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuhui","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1613-4877","authenticated-orcid":false,"given":"Jiaqian","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,29]]},"reference":[{"issue":"3","key":"8186_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clinicians. 2024;74(3):229\u201363. https:\/\/doi.org\/10.3322\/caac.21834.","journal-title":"CA Cancer J Clinicians"},{"key":"8186_CR2","doi-asserted-by":"publisher","unstructured":"Js J, Boyle TA. Molecular pathology of lung cancer. Cold Spring Harb Perspect Med. 2022;12(3):a037812. https:\/\/doi.org\/10.1101\/cshperspect.a037812.","DOI":"10.1101\/cshperspect.a037812"},{"issue":"3","key":"8186_CR3","doi-asserted-by":"publisher","first-page":"321","DOI":"10.5858\/arpa.2017-0388-CP","volume":"142","author":"NI Lindeman","year":"2018","unstructured":"Lindeman NI, Cagle PT, Aisner DL, Arcila ME, Beasley MB, Bernicker EH, et al. Updated molecular testing Guideline for the selection of lung cancer patients for treatment with targeted tyrosine kinase inhibitors: guideline from the College of American pathologists, the International association for the study of lung cancer, and the association for molecular pathology. Arch Pathol Lab Med. 2018;142(3):321\u201346. https:\/\/doi.org\/10.5858\/arpa.2017-0388-CP.","journal-title":"Arch Pathol Lab Med"},{"issue":"5","key":"8186_CR4","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","volume":"83","author":"JR Molina","year":"2008","unstructured":"Molina JR, Yang P, Cassivi SD, Schild SE, Adjei AA. Non-small cell lung cancer: epidemiology, risk factors, treatment, and survivorship. Mayo Clinic Proc. 2008;83(5):584\u201394. https:\/\/doi.org\/10.1016\/S0025-6196(11)60735-0.","journal-title":"Mayo Clinic Proc"},{"issue":"6","key":"8186_CR5","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1056\/NEJMoa2302983","volume":"389","author":"H Wakelee","year":"2023","unstructured":"Wakelee H, Liberman M, Kato T, Tsuboi M, Lee SH, Gao S, et al. Perioperative Pembrolizumab for early-stage non\u2013small-Cell lung cancer. N Engl J Med. 2023;389(6):491\u2013503. https:\/\/doi.org\/10.1056\/NEJMoa2302983.","journal-title":"N Engl J Med"},{"issue":"21","key":"8186_CR6","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.1056\/NEJMoa2202170","volume":"386","author":"PM Forde","year":"2022","unstructured":"Forde PM, Spicer J, Lu S, Provencio M, Mitsudomi T, Awad MM, et al. Neoadjuvant Nivolumab plus Chemotherapy in resectable lung cancer. N Engl J Med. 2022;386(21):1973\u201385. https:\/\/doi.org\/10.1056\/NEJMoa2202170.","journal-title":"N Engl J Med"},{"issue":"2","key":"8186_CR7","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1056\/NEJMoa2304594","volume":"389","author":"M Tsuboi","year":"2023","unstructured":"Tsuboi M, Herbst RS, John T, Kato T, Majem M, Grohe C, et al. Overall survival with osimertinib in resected EGFR-Mutated NSCLC. N Engl J Med. 2023;389(2):137\u201347. https:\/\/doi.org\/10.1056\/NEJMoa2304594.","journal-title":"N Engl J Med"},{"key":"8186_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.lungcan.2019.06.005","volume":"134","author":"A Haragan","year":"2019","unstructured":"Haragan A, Field JK, Davies MPA, Escriu C, Gruver A, Gosney JR. Heterogeneity of PD-L1 expression in non-small cell lung cancer: implications for specimen sampling in predicting treatment response. Lung Cancer. 2019;134:79\u201384. https:\/\/doi.org\/10.1016\/j.lungcan.2019.06.005.","journal-title":"Lung Cancer"},{"issue":"1\u20132","key":"8186_CR9","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000487440","volume":"85","author":"de Sousa Vml","year":"2018","unstructured":"de Sousa Vml, Carvalho L, de Sousa V. Heterogeneity in Lung Cancer. Pathobiology. 2018;85(1\u20132):96\u2013107. https:\/\/doi.org\/10.1159\/000487440.","journal-title":"Pathobiology"},{"issue":"1","key":"8186_CR10","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41568-023-00639-6","volume":"24","author":"S Li","year":"2024","unstructured":"Li S, Lu Z, Wu S, Chu T, Li B, Qi F, et al. The dynamic role of platelets in cancer progression and their therapeutic implications. Nat Rev Cancer. 2024;24(1):72\u201387. https:\/\/doi.org\/10.1038\/s41568-023-00639-6.","journal-title":"Nat Rev Cancer"},{"key":"8186_CR11","doi-asserted-by":"publisher","unstructured":"Liao K, Zhang X, Liu J, Teng F, He Y, Cheng J, et al. The role of platelets in the regulation of tumor growth and metastasis: the mechanisms and targeted therapy. MedComm (2020). 2023;4(5):e350. https:\/\/doi.org\/10.1002\/mco2.350.","DOI":"10.1002\/mco2.350"},{"issue":"1","key":"8186_CR12","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13045-018-0669-2","volume":"11","author":"M Schlesinger","year":"2018","unstructured":"Schlesinger M. Role of platelets and platelet receptors in cancer metastasis. J Hematol Oncol. 2018;11(1):125. https:\/\/doi.org\/10.1186\/s13045-018-0669-2.","journal-title":"J Hematol Oncol"},{"key":"8186_CR13","doi-asserted-by":"publisher","first-page":"245","DOI":"10.3389\/fonc.2014.00245","volume":"4","author":"L Amo","year":"2014","unstructured":"Amo L, Tamayo-Orbegozo E, Maruri N, Eguizabal C, Zenarruzabeitia O, Rinon M, et al. Involvement of platelet-tumor cell interaction in immune evasion. Potential role of podocalyxin-like protein 1. Front Oncol. 2014;4:245. https:\/\/doi.org\/10.3389\/fonc.2014.00245.","journal-title":"Front Oncol"},{"issue":"1","key":"8186_CR14","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1186\/s12890-020-1139-5","volume":"20","author":"Y Yuan","year":"2020","unstructured":"Yuan Y, Zhong H, Ye L, Li Q, Fang S, Gu W, et al. Prognostic value of pretreatment platelet counts in lung cancer: a systematic review and meta-analysis. BMC Pulm Med. 2020;20(1):96. https:\/\/doi.org\/10.1186\/s12890-020-1139-5.","journal-title":"BMC Pulm Med"},{"issue":"1","key":"8186_CR15","doi-asserted-by":"publisher","first-page":"9359","DOI":"10.1038\/s41598-023-35818-w","volume":"13","author":"M Antunes-Ferreira","year":"2023","unstructured":"Antunes-Ferreira M, D\u2019Ambrosi S, Arkani M, Post E, In \u2018t Veld SGJG, Ramaker J, et al. Tumor-educated platelet blood tests for non-small cell lung cancer detection and management. Sci Rep. 2023;13(1):9359. https:\/\/doi.org\/10.1038\/s41598-023-35818-w.","journal-title":"Sci Rep"},{"key":"8186_CR16","doi-asserted-by":"publisher","first-page":"102863","DOI":"10.1016\/j.critrevonc.2020.102863","volume":"146","author":"L Liu","year":"2020","unstructured":"Liu L, Lin F, Ma X, Chen Z, Yu J. Tumor-educated platelet as liquid biopsy in lung cancer patients. Crit Rev Oncol\/Hematol. 2020;146:102863. https:\/\/doi.org\/10.1016\/j.critrevonc.2020.102863.","journal-title":"Crit Rev Oncol\/Hematol"},{"issue":"5","key":"8186_CR17","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.ccell.2015.09.018","volume":"28","author":"MG Best","year":"2015","unstructured":"Best MG, Sol N, Kooi I, Tannous J, Westerman BA, Rustenburg F, et al. RNA-Seq of tumor-educated platelets enables blood-based Pan-cancer, multiclass, and molecular pathway cancer Diagnostics. Cancer Cell. 2015;28(5):666\u201376. https:\/\/doi.org\/10.1016\/j.ccell.2015.09.018.","journal-title":"Cancer Cell"},{"issue":"1","key":"8186_CR18","doi-asserted-by":"publisher","first-page":"4388","DOI":"10.1038\/s41467-024-48700-8","volume":"15","author":"M De Zuani","year":"2024","unstructured":"De Zuani M, Xue H, Park JS, Dentro SC, Seferbekova Z, Tessier J, et al. Single-cell and spatial transcriptomics analysis of non-small cell lung cancer. Nat Commun. 2024;15(1):4388. https:\/\/doi.org\/10.1038\/s41467-024-48700-8.","journal-title":"Nat Commun"},{"issue":"1","key":"8186_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1038\/s41392-022-01130-8","volume":"7","author":"C Wang","year":"2022","unstructured":"Wang C, Yu Q, Song T, Wang Z, Song L, Yang Y, et al. The heterogeneous immune landscape between lung adenocarcinoma and squamous carcinoma revealed by single-cell RNA sequencing. Sig Transduct Target Ther. 2022;7(1):289. https:\/\/doi.org\/10.1038\/s41392-022-01130-8.","journal-title":"Sig Transduct Target Ther"},{"issue":"5","key":"8186_CR20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","volume":"50","author":"R Zilionis","year":"2019","unstructured":"Zilionis R, Engblom C, Pfirschke C, Savova V, Zemmour D, Saatcioglu HD, et al. Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species. Immunity. 2019;50(5):1317\u201334.e10. https:\/\/doi.org\/10.1016\/j.immuni.2019.03.009.","journal-title":"Immunity"},{"issue":"8","key":"8186_CR21","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1038\/s41591-018-0096-5","volume":"24","author":"D Lambrechts","year":"2018","unstructured":"Lambrechts D, Wauters E, Boeckx B, Aibar S, Nittner D, Burton O, et al. Phenotype molding of stromal cells in the lung tumor microenvironment. Nat Med. 2018;24(8):1277\u201389. https:\/\/doi.org\/10.1038\/s41591-018-0096-5.","journal-title":"Nat Med"},{"issue":"3","key":"8186_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/j.ccell.2023.12.021","volume":"42","author":"L Cords","year":"2024","unstructured":"Cords L, Engler S, Haberecker M, Ruschoff JH, Moch H, de Souza N, et al. Cancer-associated fibroblast phenotypes are associated with patient outcome in non-small cell lung cancer. Cancer Cell. 2024;42(3):396\u2013412.e5. https:\/\/doi.org\/10.1016\/j.ccell.2023.12.021.","journal-title":"Cancer Cell"},{"issue":"1","key":"8186_CR23","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/s41467-023-35832-6","volume":"14","author":"CJ Hanley","year":"2023","unstructured":"Hanley CJ, Waise S, Ellis MJ, Lopez MA, Pun WY, Taylor J, et al. Single-cell analysis reveals prognostic fibroblast subpopulations linked to molecular and immunological subtypes of lung cancer. Nat Commun. 2023;14(1):387. https:\/\/doi.org\/10.1038\/s41467-023-35832-6.","journal-title":"Nat Commun"},{"issue":"7","key":"8186_CR24","doi-asserted-by":"publisher","first-page":"2646","DOI":"10.21037\/tlcr-2025-244","volume":"14","author":"M Xiao","year":"2025","unstructured":"Xiao M, Deng Y, Guo H, Ren Z, He Y, Ren X, et al. Single-cell and spatial transcriptomics profile the interaction of SPP1+ macrophages and FAP+ fibroblasts in non-small cell lung cancer. Transl Lung Cancer Res. 2025;14(7):2646\u201369. https:\/\/doi.org\/10.21037\/tlcr-2025-244.","journal-title":"Transl Lung Cancer Res"},{"key":"8186_CR25","doi-asserted-by":"publisher","unstructured":"Chen C, Guo Q, Liu Y, Hou Q, Liao M, Guo Y, et al. Single-cell and spatial transcriptomics reveal POSTN + cancer-associated fibroblasts correlated with immune suppression and tumour progression in non-small cell lung cancer. Clin Transl Med. 2023;13(12):e 1515. https:\/\/doi.org\/10.1002\/ctm2.1515.","DOI":"10.1002\/ctm2.1515"},{"issue":"6","key":"8186_CR26","doi-asserted-by":"publisher","first-page":"3100","DOI":"10.3390\/ijms23063100","volume":"23","author":"M Chebbo","year":"2022","unstructured":"Chebbo M, Assou S, Pantesco V, Duez C, Alessi MC, Chanez P, et al. Platelets purification is a crucial step for transcriptomic analysis. IJMS. 2022;23(6):3100. https:\/\/doi.org\/10.3390\/ijms23063100.","journal-title":"IJMS"},{"key":"8186_CR27","doi-asserted-by":"publisher","unstructured":"Karp JM, Modrek AS, Ezhilarasan R, Zhang ZY, Ding Y, Graciani M, et al. Deconvolution of the tumor-educated platelet transcriptome reveals activated platelet and inflammatory cell transcript signatures. JCI Insight. 2024;9(19). https:\/\/doi.org\/10.1172\/jci.insight.178719.","DOI":"10.1172\/jci.insight.178719"},{"issue":"7","key":"8186_CR28","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923\u201330. https:\/\/doi.org\/10.1093\/bioinformatics\/btt656.","journal-title":"Bioinformatics"},{"issue":"1","key":"8186_CR29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29(1):15\u201321. https:\/\/doi.org\/10.1093\/bioinformatics\/bts635.","journal-title":"Bioinformatics"},{"key":"8186_CR30","doi-asserted-by":"publisher","unstructured":"Law CW, Chen Y, Shi W, Smyth GK. Voom: precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014;15(2):R29. https:\/\/doi.org\/10.1186\/gb-2014-15-2-r29.","DOI":"10.1186\/gb-2014-15-2-r29"},{"issue":"43","key":"8186_CR31","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"8186_CR32","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1038\/s41467-020-16164-1","volume":"11","author":"N Kim","year":"2020","unstructured":"Kim N, Kim HK, Lee K, Hong Y, Cho JH, Choi JW, et al. Single-cell RNA sequencing demonstrates the molecular and cellular reprogramming of metastatic lung adenocarcinoma. Nat Commun. 2020;11(1):2285. https:\/\/doi.org\/10.1038\/s41467-020-16164-1.","journal-title":"Nat Commun"},{"key":"8186_CR33","doi-asserted-by":"publisher","unstructured":"Cancer Genome atlas Research N: comprehensive molecular profiling of lung adenocarcinoma. Nature. 2014;511(7511):543\u201350. https:\/\/doi.org\/10.1038\/nature13385.","DOI":"10.1038\/nature13385"},{"key":"8186_CR34","doi-asserted-by":"publisher","unstructured":"Cancer Genome atlas Research N: comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012;489(7417):519\u201325. https:\/\/doi.org\/10.1038\/nature11404.","DOI":"10.1038\/nature11404"},{"issue":"2","key":"8186_CR35","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2017.07.004","volume":"32","author":"MG Best","year":"2017","unstructured":"Best MG, Sol N, \u2018t Veld S, Vancura A, Muller M, Niemeijer A-LN, et al. Huis in \u2018t Veld AE, leurs C et al: swarm intelligence-enhanced detection of non-small-cell lung cancer using tumor-educated platelets. Cancer Cell. 2017;32(2):238\u201352.e9. https:\/\/doi.org\/10.1016\/j.ccell.2017.07.004.","journal-title":"Cancer Cell"},{"issue":"1","key":"8186_CR36","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1038\/s41467-021-21254-9","volume":"12","author":"Z Zhang","year":"2021","unstructured":"Zhang Z, Hernandez K, Savage J, Li S, Miller D, Agrawal S, et al. Uniform genomic data analysis in the NCI genomic data Commons. Nat Commun. 2021;12(1):1226. https:\/\/doi.org\/10.1038\/s41467-021-21254-9.","journal-title":"Nat Commun"},{"issue":"5","key":"8186_CR37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler A, Hoffman P, Smibert P, Papalexi E, Satija R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol. 2018;36(5):411\u201320. https:\/\/doi.org\/10.1038\/nbt.4096.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"8186_CR38","first-page":"1001","volume":"85","author":"T Onodera","year":"1984","unstructured":"Onodera T, Goseki N, Kosaki G. [Prognostic nutritional index in gastrointestinal surgery of malnourished cancer patients]. Nihon Geka Gakkai Zasshi. 1984;85(9):1001\u201305.","journal-title":"Nihon Geka Gakkai Zasshi"},{"issue":"13","key":"8186_CR39","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1002\/sim.1802","volume":"23","author":"MJ Pencina","year":"2004","unstructured":"Pencina MJ, D\u2019Agostino RB. Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation. Stat Med. 2004;23(13):2109\u201323. https:\/\/doi.org\/10.1002\/sim.1802.","journal-title":"Stat Med"},{"issue":"4","key":"8186_CR40","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell Jr","year":"1996","unstructured":"Harrell FE Jr, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Statist. Med. 1996;15(4):361\u201387. https:\/\/doi.org\/10.1002\/(SICI)1097-0258(19960229)15:4%3C361::AID-SIM168%3E3.0.CO;2-4.","journal-title":"Statist. Med"},{"issue":"1","key":"8186_CR41","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1002\/mpr.329","volume":"20","author":"MJ Azur","year":"2011","unstructured":"Azur MJ, Stuart EA, Frangakis C, Leaf PJ. Multiple imputation by chained equations: what is it and how does it work? Int J Methods Psych Res. 2011;20(1):40\u201349. https:\/\/doi.org\/10.1002\/mpr.329.","journal-title":"Int J Methods Psych Res"},{"issue":"5","key":"8186_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v039.i05","volume":"39","author":"N Simon","year":"2011","unstructured":"Simon N, Friedman J, Hastie T, Tibshirani R. Regularization paths for Cox\u2019s proportional hazards model via coordinate descent. J Stat Soft. 2011;39(5):1\u201313. https:\/\/doi.org\/10.18637\/jss.v039.i05.","journal-title":"J Stat Soft"},{"issue":"13\u201314","key":"8186_CR43","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1016\/j.spl.2010.02.020","volume":"80","author":"H Ishwaran","year":"2010","unstructured":"Ishwaran H, Kogalur UB. Consistency of random survival forests. Stat Probab Lett. 2010;80(13\u201314):1056\u201364. https:\/\/doi.org\/10.1016\/j.spl.2010.02.020.","journal-title":"Stat Probab Lett"},{"issue":"1","key":"8186_CR44","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z, et al. Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer. Nat Commun. 2022;13(1):1742. https:\/\/doi.org\/10.1038\/s41467-022-29366-6.","journal-title":"Nat Commun"},{"issue":"4","key":"8186_CR45","first-page":"5379","volume":"8","author":"X Zhang","year":"2015","unstructured":"Zhang X, Ran Y. Prognostic role of elevated platelet count in patients with lung cancer: a systematic review and meta-analysis. Int J Clin Exp Med. 2015;8(4):5379\u201387.","journal-title":"Int J Clin Exp Med"},{"issue":"1","key":"8186_CR46","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1159\/000533604","volume":"102","author":"F Nishihara-Kato","year":"2024","unstructured":"Nishihara-Kato F, Imai H, Tsuda T, Wasamoto S, Nagai Y, Kishikawa T, et al. Prognostic potential of the prognostic nutritional index in non-small cell lung cancer patients receiving pembrolizumab combination therapy with Carboplatin and Paclitaxel\/Nab-Paclitaxel. Oncology. 2024;102(1):30\u201342. https:\/\/doi.org\/10.1159\/000533604.","journal-title":"Oncology"},{"issue":"2","key":"8186_CR47","doi-asserted-by":"publisher","first-page":"423","DOI":"10.3390\/diagnostics12020423","volume":"12","author":"S Tanaka","year":"2022","unstructured":"Tanaka S, Uchino J, Yokoi T, Kijima T, Goto Y, Suga Y, et al. Prognostic nutritional index and lung immune prognostic index as prognostic predictors for combination therapies of immune checkpoint inhibitors and cytotoxic anticancer Chemotherapy for patients with advanced non-small cell lung cancer. Diagn (Basel). 2022;12(2):423. https:\/\/doi.org\/10.3390\/diagnostics12020423.","journal-title":"Diagn (Basel)"},{"key":"8186_CR48","doi-asserted-by":"publisher","unstructured":"Xia H, Zhang W, Zheng Q, Zhang Y, Mu X, Wei C, et al. Predictive value of the prognostic nutritional index in advanced non-small cell lung cancer patients treated with immune checkpoint inhibitors: a systematic review and meta-analysis. Heliyon. 2023;9(8):e17400. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17400.","DOI":"10.1016\/j.heliyon.2023.e17400"},{"key":"8186_CR49","doi-asserted-by":"publisher","first-page":"1213255","DOI":"10.3389\/fnut.2023.1213255","volume":"10","author":"X Yan","year":"2023","unstructured":"Yan X, Wang J, Mao J, Wang Y, Wang X, Yang M, et al. Identification of prognostic nutritional index as a reliable prognostic indicator for advanced lung cancer patients receiving immune checkpoint inhibitors. Front Nutr. 2023;10:1213255. https:\/\/doi.org\/10.3389\/fnut.2023.1213255.","journal-title":"Front Nutr"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08186-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08186-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08186-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,28]],"date-time":"2026-05-28T15:19:29Z","timestamp":1779981569000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08186-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,29]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8186"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08186-y","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,29]]},"assertion":[{"value":"13 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Human lung cancer tissues and matched adjacent tissues were collected from The First Affiliated Hospital of Soochow University and The Fourth Affiliated Hospital of Soochow University. The study was approved by Soochow University (approval No. 2021\u2013012). All procedures involving human tissues and de-identified clinical data were conducted in accordance with the Declaration of Helsinki. Written informed consent was obtained from all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"715"}}